Literature DB >> 29687426

[Diagnosis and treatment of Osler's disease].

F Haubner1, T Kühnel2.   

Abstract

Osler's disease is an autosomal dominant hereditary syndrome which belongs to the group of orphan diseases. Affected patients suffer primarily from severe epistaxis. Diagnosis is based on the Curaçao criteria and molecular genetic tests. Organ manifestations can be found in the form of arteriovenous shunts in the lung, liver, and gastrointestinal tract; more rarely also in the central nervous system (CNS) and other parts of the body. Many patients with gastrointestinal and other organ manifestations are frequently clinically asymptomatic; therefore, organ screening is essential to avoid later complications and should be performed in centers with particular expertise. No curative therapy currently exists. From the otolaryngologist's perspective, nasal mucosa treatments and endonasal laser applications are important and effective therapeutic approaches to epistaxis. Pharmacological interventions are focused on compensation of haploinsufficiency as well as antiangiogenetic approaches. Severe side effects have to be considered.

Entities:  

Keywords:  Epistaxis; Osler–Rendu–Weber disease; Rare diseases; Telangiectasia, hereditary hemorrhagic; Vascular diseases

Mesh:

Year:  2018        PMID: 29687426     DOI: 10.1007/s00106-018-0503-8

Source DB:  PubMed          Journal:  HNO        ISSN: 0017-6192            Impact factor:   1.284


  28 in total

Review 1.  [Treatment of recurrent epistaxis in Rendu-Osler-Weber disease].

Authors:  J A Werner; U W Geisthoff; B M Lippert; H Rudert
Journal:  HNO       Date:  1997-09       Impact factor: 1.284

2.  Influence of temporary nasal occlusion (tNO) on epistaxis frequency in patients with hereditary hemorrhagic telangiectasia (HHT).

Authors:  Kornelia E C Wirsching; Frank Haubner; Thomas S Kühnel
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-01-09       Impact factor: 2.503

Review 3.  The physiological role of endoglin in the cardiovascular system.

Authors:  José M López-Novoa; Carmelo Bernabeu
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-07-23       Impact factor: 4.733

Review 4.  Endoglin and alk1 as therapeutic targets for hereditary hemorrhagic telangiectasia.

Authors:  Lidia Ruiz-Llorente; Eunate Gallardo-Vara; Elisa Rossi; David M Smadja; Luisa M Botella; Carmelo Bernabeu
Journal:  Expert Opin Ther Targets       Date:  2017-08-20       Impact factor: 6.902

Review 5.  Hereditary haemorrhagic telangiectasia: current views on genetics and mechanisms of disease.

Authors:  S A Abdalla; M Letarte
Journal:  J Med Genet       Date:  2005-05-06       Impact factor: 6.318

6.  Genetic variants of Adam17 differentially regulate TGFβ signaling to modify vascular pathology in mice and humans.

Authors:  Kyoko Kawasaki; Julia Freimuth; Dominique S Meyer; Marie M Lee; Akiko Tochimoto-Okamoto; Michael Benzinou; Frederic F Clermont; Gloria Wu; Ritu Roy; Tom G W Letteboer; Johannes Kristian Ploos van Amstel; Sophie Giraud; Sophie Dupuis-Girod; Gaeten Lesca; Cornelius J J Westermann; Robert J Coffey; Rosemary J Akhurst
Journal:  Proc Natl Acad Sci U S A       Date:  2014-05-08       Impact factor: 11.205

Review 7.  The Lung in Hereditary Hemorrhagic Telangiectasia.

Authors:  Sophie Dupuis-Girod; Vincent Cottin; C L Shovlin
Journal:  Respiration       Date:  2017-08-30       Impact factor: 3.580

Review 8.  Hereditary haemorrhagic telangiectasia: a clinical and scientific review.

Authors:  Fatima S Govani; Claire L Shovlin
Journal:  Eur J Hum Genet       Date:  2009-04-01       Impact factor: 4.246

9.  Pathogenesis of arteriovenous malformations in the absence of endoglin.

Authors:  Marwa Mahmoud; Kathleen R Allinson; Zhenhua Zhai; Rachael Oakenfull; Pranita Ghandi; Ralf H Adams; Marcus Fruttiger; Helen M Arthur
Journal:  Circ Res       Date:  2010-03-11       Impact factor: 17.367

10.  BMP9 mutations cause a vascular-anomaly syndrome with phenotypic overlap with hereditary hemorrhagic telangiectasia.

Authors:  Whitney L Wooderchak-Donahue; Jamie McDonald; Brendan O'Fallon; Paul D Upton; Wei Li; Beth L Roman; Sarah Young; Parker Plant; Gyula T Fülöp; Carmen Langa; Nicholas W Morrell; Luisa M Botella; Carmelo Bernabeu; David A Stevenson; James R Runo; Pinar Bayrak-Toydemir
Journal:  Am J Hum Genet       Date:  2013-08-22       Impact factor: 11.025

View more
  1 in total

Review 1.  Rare Diseases of the Oral Cavity, Neck, and Pharynx.

Authors:  Christoph A Reichel
Journal:  Laryngorhinootologie       Date:  2021-04-30       Impact factor: 1.057

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.